Priya Sachdeva

Stock Analyst at UBS

(2.54)

# 2,109

Out of 5,182 analysts

6

Total ratings

83.33%

Success rate

17.67%

Average return

Main Sectors:

Top Industries:

Medical Devices

Stocks Rated by Priya Sachdeva

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	NPCE NeuroPace	Maintains: Buy	$18 → $22	$15.35	+43.32%	2	Dec 16, 2025
	PEN Penumbra	Maintains: Buy	$330 → $335	$332.17	+0.85%	4	Jul 30, 2025

NeuroPace

Dec 16, 2025

Maintains: Buy

Price Target: $18 → $22

Current: $15.35

Upside: +43.32%

Penumbra

Jul 30, 2025

Maintains: Buy

Price Target: $330 → $335

Current: $332.17

Upside: +0.85%